Bovine peptic casein hydrolysate ameliorates cardiovascular risk factors in a model of ApoE-deficient mice but not overweight, mildly hypercholesterolaemic men.

Show simple item record Chan, YK en McGill, Anne-Thea en Kanwar, RK en Krissansen, Geoffrey en Haggarty, N en Xin, L en Poppitt, Sally en 2014-08-14T00:58:13Z en 2014-04 en
dc.identifier.citation Current Research in Nutrition and Food Science, 2014, 2 (1), pp. 8 - 19 en
dc.identifier.issn 2347-467X en
dc.identifier.uri en
dc.description.abstract Associations have been shown between consumption of bovine dairy and decreased prevalence of metabolic related disorders. Milk peptides may promote both angiotensin-I- converting enzyme (ACE) inhibition for blood pressure (BP) lowering and insulin action for better glycaemic control. Less is known of other metabolic parameters. The aim of this study was to investigate effects of dairy peptic casein hydrolysate (CH) on markers of cardiovascular disease (CVD) risk in (1) an apolipoproteinE (ApoE) - deficient mouse model of high-fat fed hypercholesterolaem- ia, and, (2) a clinical study of moderate overweight and hypercholesterolaemia. In Trial 1, ApoE-deficient mice were supplemented with high dose CH (~1g/kg body weight) in a randomised, 9-wk, parallel design intervention, and blood and tissue samples harvested. In Trial 2, 24 mildly hypercholesterolaemic men were supplemented with lower dose CH (~0.1g/kg body weight, 10g/day, 3-wks) and matched whey protein control (WP, 10g/day, 3-wks) in a randomised, 9-wk, cross-over design intervention. Diets were separated by a 3-wk washout. Fasting blood and urine samples were collected, and blood pressure (BP) measured weekly. Clinical trial registration number, ACTRN 12611001013954. In ApoE-deficient mice, administration of CH significantly inhibited circulating total cholesterol concentrations by 37% (TC, P<0.01) and decreased aorta atherosclerotic lesion score by 25% (P<0.01). In the clinical study there were no significant differential effects of CH supplementation on CV markers, including serum lipids (TC, LDL-C, HDL-C, triglyceride), glucose and BP. Whilst high dose bovine peptic CH attenuated CVD risk in a murine ApoE deficient model of aggressive hypercholesterolaemia, no evidence of amelioration of risk by supplementation with a lower dose of CH in an overweight population of mildly hypercholesterolaemic men was found. en
dc.relation.ispartofseries Current Research in Nutrition and Food Science en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from en
dc.rights.uri en
dc.title Bovine peptic casein hydrolysate ameliorates cardiovascular risk factors in a model of ApoE-deficient mice but not overweight, mildly hypercholesterolaemic men. en
dc.type Journal Article en
dc.identifier.doi 10.12944/CRNFSJ.2.1.02 en
pubs.issue 1 en
pubs.begin-page 8 en
pubs.volume 2 en
pubs.end-page 19 en
dc.rights.accessrights en
pubs.subtype Article en
pubs.elements-id 448513 en Science en Biological Sciences en
dc.identifier.eissn 2322-0007 en
pubs.record-created-at-source-date 2014-08-04 en

Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace